Deva Fitra Firdausa Anwar

Deva Fitra Firdausa Anwar

Auto-generated profile, based on publicly available information

Deva Fitra Firdausa Anwar


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2025 in Sleep Medicine Research
Verified
Journal Article
Open access
PDF file
MHMoh Ikhsan Hanafi
Moh Ikhsan Hanafi
FFFidiana Fidiana
Fidiana Fidiana
IIIrfiansyah Irwadi
Irfiansyah Irwadi
WIWardah Rahmatul Islamiyah
Wardah Rahmatul Islamiyah
DADeva Fitra Firdausa Anwar
Deva Fitra Firdausa Anwar
ZPZaidaan Alfayyadh Pohan
Zaidaan Alfayyadh Pohan
Background and Objective Rapid eye movement (REM) sleep behavior disorder (RBD) is a sleep disorder characterized by REM sleep without atonia, resulting in physical movements that interrupt sleep quality. Melatonin has been suggested as an alternative therapy for patient intolerant to clonazepam. A systematic review and meta-analysis were conducted to evaluate the effectiveness of melatonin in improving sleep quality in RBD patients, analyzing sleep parameters both objectively with polysomnography (PSG) and subjectively with sleep questionnaires.Methods This systematic review and meta-analysis adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines and the Cochrane Handbook. A comprehensive search was performed across various databases (PubMed, Web of Science, Scopus, Taylor and Francis, ProQuest). Study quality was assessed using the Cochrane Risk of Bias 2.0 tool, and data were analyzed using R Studio.Results Statistically, the results of PSG analysis showed a significant improvement in the sleep of RBD patients receiving melatonin, characterized by a decrease in wakefulness after sleep onset (WASO) (mean difference [MD]=-11.17, 95% confidence interval [CI] [-13.35; -8.99], p<0.0001) and sleep onset latency (SOL) (MD=-7.05, 95% CI [-11.40; -2.69], p=0.0015), as well as an increase in time in REM sleep (MD=3.93, 95% CI [2.88; 4.99], p<0.00001). However, evaluation using sleep questionnaires overall did not show significant results (pooled MD=0.18, 95% CI [-0.65; 1.02], p=0.6681).Conclusions PSG analysis showed that melatonin effectively improved objective sleep quality in RBD patients. However, questionnaire-based evaluations revealed that melatonin was not particularly effective in treating a subjective sleep complaint.

31 March 2025 in Sleep Medicine Research
Verified
Journal Article
Open access
PDF file
DADeva Fitra Firdausa Anwar
Deva Fitra Firdausa Anwar
FFFidiana Fidiana
Fidiana Fidiana
IIIrfiansyah Irwadi
Irfiansyah Irwadi
ARAlfian Nur Nur Rosyid
Alfian Nur Nur Rosyid
ZSZaskia Nafisa Salma
Zaskia Nafisa Salma
MHMuhammad Farhan Hibatulloh
Muhammad Farhan Hibatulloh
Background and Objective Co-morbid insomnia and sleep apnea (COMISA) is a comorbid condition between insomnia and obstructive sleep apnea (OSA) with a prevalence in 2013 to 2018 of 30%–50% in the world. COMISA patients experience greater impairment in daytime function and quality of life compared to patients with insomnia or OSA alone. COMISA treatment tends to focus on OSA disease therapy, hence, it is less effective. Therefore, other treatment methods are needed to improve the success of therapy. This systematic review and meta-analysis evaluate the effects of cognitive behavioral therapy for insomnia (CBT-I) on patients with COMISA compared to control or positive airway pressure (PAP).Methods The selection of studies for this systematic review and meta-analysis used the PRISMA 2020 guidelines and the Cochrane Handbook for Systematic Reviews of Interventions. A systematic search for studies was conducted from Sage, PubMed, Web of Science, Scopus, EBSCO, and Taylor and Francis accessed in March 2024 and selected according to the inclusion and exclusion criteria. Risk of bias was analyzed with the Cochrane Risk of Bias 2.0 Tool, then meta-analysis was performed using Review Manager V5.4.1.Results Overall, significant changes in sleep diary outcomes were found (mean difference [MD]=7.54, 95% confidence interval [CI]=4.07 to 11.00, p<0.001; MD=-19.97, 95% CI=-22.26 to -17.68, p<0.001, respectively) in CBT-I compared to control. In addition, in the CBT-I+PAP intervention compared to PAP, there were significant changes in the descending sleep diary output (MD=-16.92, 95% CI=-27.08 to -6.67, p<0.001) as well as in the sleep questionnaire output (MD=2.13, 95% CI=1.88 to 2.39, p<0.001; MD=-5.91, 95% CI=-10.41 to -1.40, p=0.01, respectively).Conclusions CBT-I showed effectiveness in patients with COMISA. CBT-I was associated with significant improvements in sleep diary, actigraphy, questionnaires, and compliance with PAP use.

25 June 2026 in Journal of Asian Medical Students' Association
Verified
Journal Article
Open access
SNSamuel Nababan
Samuel Nababan
GUGresita Novelia Uirianto
Gresita Novelia Uirianto
Juan Fransiscus WiraJuan Fransiscus Wira
Juan Fransiscus Wira
WTWhitney Joycelyn Tenaya
Whitney Joycelyn Tenaya
DADeva Fitra Firdausa Anwar
Deva Fitra Firdausa Anwar
Introduction: Serum vitamin D concentration has been associated with PPD in previous studies. However, whether there is a dose-response relationship and if its supplementation during pregnancy can improve symptoms after delivery remains unclear. Objective: To evaluate the evidence on the association of vitamin D concentration during pregnancy towards PPD and whether its supplementation can improve symptoms Methods: Five databases were searched on September 27, 2025. Cohort studies were included for dose-response meta-analysis (DRMA), while randomized controlled trials (RCTs) were included for meta-analysis (MA) of supplementation. The outcome for MA of supplementation was postpartum Edinburgh Postnatal Depression Scale (EPDS) score using the effect measure of mean difference (MD), while the outcome for DRMA was the odds ratio (OR) of PPD after delivery. Certainty was assessed using GRADE for MA of supplementation. Results: Two prospective cohort studies were included for DRMA and two RCTs were included for MA of supplementation. There was a significant log linear dose-response relationship between vitamin D serum concentration and developing PPD with β = -0.0256 (95% CI = -0.0454 to -0.0057). Every 10 nmol/L increase was associated with OR = 0.77 (95% CI = 0.63 to 0.94). Meta-analysis of supplementation found a significant reduction in EPDS scores at 4 weeks after delivery (MD = -2.70; 95% CI = -3.68 to -1.71; low certainty). Conclusion: Vitamin D serum concentration during pregnancy is log-linearly associated with developing PPD after delivery and its supplementation during pregnancy may improve PPD symptoms. Further larger and high quality studies with more diverse pregnant populations are needed to improve certainty and generalizability of evidence. Keywords: Maternal health, Postpartum depression, Vitamin D